Hong Kong Customs detects two drug trafficking cases involving passengers at airport
Hong Kong Customs detected two drug trafficking cases involving baggage concealment at Hong Kong International Airport yesterday (June 5) and today (June 6), and seized a total of about 3.4 kilograms of suspected cocaine and 16 kg of suspected cannabis buds, with a total estimated market value of about $5.6 million. Two women were arrested.
In the first case, a 23-year-old female passenger arrived in Hong Kong from Sao Paulo, Brazil, via Istanbul, Turkey, yesterday afternoon. During customs clearance, Customs officer found about 3.4 kg of suspected cocaine concealed inside two statues in her check-in suitcase. Thirty-four duty-not-paid cigarettes and one piece of alternative smoking were also found inside her carry-on baggage. The woman was then arrested.
In the second case, a 22-year-old female passenger arrived in Hong Kong from Bangkok, Thailand, today. During customs clearance, Customs officers found about 16kg of suspected cannabis buds inside her check-in baggage. She was subsequently arrested.
Investigations of the two cases are ongoing.
Customs will continue to step up enforcement against drug trafficking activities through intelligence analysis. The department also reminds members of the public to stay alert and not participate in drug trafficking activities for monetary return. They must not accept hiring or delegation from another party to carry controlled items into and out of Hong Kong. They are also reminded not to carry unknown items for other people.
Customs will continue to apply a risk assessment approach and focus on selecting passengers from high-risk regions for clearance to combat transnational drug trafficking activities.
Under the Dangerous Drugs Ordinance, trafficking in a dangerous drug is a serious offence. The maximum penalty upon conviction is a fine of $5 million and life imprisonment.
Under the Dutiable Commodities Ordinance, cigarettes are dutiable goods to which the DCO applies. Any person who imports, deals with, possesses, sells or buys illicit cigarettes commits an offence. The maximum penalty upon conviction is a fine of $2 million and imprisonment for seven years.
Under the Import and Export Ordinance, importing an alternative smoking product is liable to a maximum fine of $2 million and imprisonment for seven years.
Members of the public may report any suspected drug trafficking activities to Customs' 24-hour hotline 182 8080 or its dedicated crime-reporting email account (crimereport@customs.gov.hk) or online form (eform.cefs.gov.hk/form/ced002).
Hong Kong Customs detected two drug trafficking cases involving baggage concealment at Hong Kong International Airport yesterday (June 5) and today (June 6), and seized about 3.4 kilograms of suspected cocaine and 16kg of suspected cannabis buds, with a total estimated market value of about $ 5.6 million. Photo shows the suspected cannabis buds seized in the second case. Source: HKSAR Government Press Releases
Hong Kong Customs detected two drug trafficking cases involving baggage concealment at Hong Kong International Airport yesterday (June 5) and today (June 6), and seized about 3.4 kilograms of suspected cocaine and 16kg of suspected cannabis buds, with a total estimated market value of about $ 5.6 million. Photo shows the suspected cocaine concealed in one of the statues in the first case. Source: HKSAR Government Press Releases
Hong Kong Customs detected two drug trafficking cases involving baggage concealment at Hong Kong International Airport yesterday (June 5) and today (June 6), and seized about 3.4 kilograms of suspected cocaine and 16kg of suspected cannabis buds, with a total estimated market value of about $ 5.6 million. Photo shows one of the statues found with suspected cocaine in the first case. Source: HKSAR Government Press Releases
DH convenes 14th Meeting of International Advisory Board on Hong Kong Chinese Materia Medica Standards
The Department of Health (DH) today (July 14) convened the 14th Meeting of the International Advisory Board (IAB) on Hong Kong Chinese Materia Medica Standards (HKCMMS) to review the reference standards for 16 types of Chinese Materia Medica (CMM) commonly used in Hong Kong, and to discuss the future development of the HKCMMS. Over 60 experts from the Chinese Mainland, overseas and Hong Kong attended the meeting.
Since 2002, the DH has been implementing the HKCMMS project in phases to develop standards for commonly used CMM in Hong Kong to ensure their safety and quality.
In his opening remarks, the Director of Health and the Chairperson of the IAB, Dr Ronald Lam, said, "One of the key initiatives of the Government Chinese Medicines Testing Institute (GCMTI) under the DH is the implementation of the HKCMMS. With the publication of the Volume 12 of the HKCMMS, standards for 357 types of CMM have been established so far. They have become widely recognised international reference standards for Chinese medicine testing and certification, thereby promoting the high-quality scientific development of Chinese medicine. In addition, the work of GCMTI is closely aligned with national priorities. The National 15th Five-Year Plan made it clear that we need to 'advance the inheritance and innovation of Chinese medicine' and 'promote the integration of Chinese and Western medicine'. It also calls for us to 'strengthen the conservation and utilisation of Chinese medicine resources', 'improve the quality of Chinese medicine, and build up and strengthen the Chinese medicine industry'. These are exactly the goals that the HKCMMS Project is helping to achieve - by setting rigorous quality standards for CMM and conducting applied research and development on testing methods that underpin the entire industry, establishing the Hong Kong Special Administrative Region as a bridgehead for the global expansion of Chinese Medicine."
Dr Lam emphasised that the success of the HKCMMS project depends on the active collaboration of stakeholders across different sectors. He expressed his sincere appreciation to the four research partners attending the meeting, commending their dedicated contributions to advancing the project's research efforts. They were the National Institutes for Food and Drug Control, the Chinese University of Hong Kong, the Hong Kong Polytechnic University and the China Medical University. He also thanked the Government Laboratory for conducting inter-laboratory verification studies. Dr Lam emphasised that these collaborations are crucial for establishing a rigorous and solid scientific foundation for the HKCMMS and gaining international credibility. The DH is also deeply grateful to the National Medical Products Administration, the National Administration of Traditional Chinese Medicine and the Chinese Pharmacopoeia Commission for their continuous valuable advice and support in developing the HKCMMS. To align with the National 15th Five-Year Plan to advance the inheritance, innovation and high-quality development of Chinese medicine, expand and promote Chinese medicine culture, the DH will continue to steadfastly promote the development of Chinese medicine and better integrate into and serve the overall national development.
The two-day meeting brought together experts from the Chinese Mainland, Australia, Austria, Canada, Germany, Japan, Thailand, the United Kingdom and the United States, as well as representatives from research institutions, the DH and the Government Laboratory of the Hong Kong Special Administrative Region. The 16 types of CMM commonly used in Hong Kong that were discussed at the meeting included Bambusae Caulis in Taenias, Pyrolae Herba, Natrii Sulfas, Dichroae Radix, Dioscoreae Hypoglaucae Rhizoma, Cynanchi Atrati Radix et Rhizoma, Jasmini Flos, Tinosporae Caulis, Inulae Flos, Haematitum, Lasiosphaera seu Calvatia, Vespae Nidus, Dioscoreae Rhizoma, Aconiti Kusnezoffii Folium, Meliae Cortex and Tripterygii Wilfordii Radix.
Previous editions of the HKCMMS can be accessed at the website of the Chinese Medicine Regulatory Office of the DH.
DH convenes 14th Meeting of International Advisory Board on Hong Kong Chinese Materia Medica Standards Source: HKSAR Government Press Releases
DH convenes 14th Meeting of International Advisory Board on Hong Kong Chinese Materia Medica Standards Source: HKSAR Government Press Releases
DH convenes 14th Meeting of International Advisory Board on Hong Kong Chinese Materia Medica Standards Source: HKSAR Government Press Releases
